Supn stock price target

SUPN - Supernus Pharmaceuticals Inc Stock quote - … Find real-time SUPN - Supernus Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SUPN - Supernus Pharmaceuticals Inc Stock quote - CNNMoney.com Markets

Supernus Pharmaceuticals - SUPN - Stock Price & News | The ... Real time Supernus Pharmaceuticals (SUPN) stock price quote, stock graph, news & analysis. Real time Supernus Pharmaceuticals (SUPN) stock price quote, stock graph, news & analysis. Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis ... Get breaking news and analysis on Supernus Pharmaceuticals, Inc. (SUPN) stock, price quote and chart, trading and investing tools. Supernus Pharmaceuticals, Inc. - SUPN - Stock Price Today ...

SUPN - Supernus Pharmaceuticals Inc Stock quote - …

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. SUPN:NASDAQ GM Stock Quote - Supernus Pharmaceuticals Inc ... Stock analysis for Supernus Pharmaceuticals Inc (SUPN:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SUPN -- Is Its Stock Price A Worthy Investment? Learn More. SUPN Stock Summary. With a one year PEG ratio of 105.07, Supernus Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 76.1% of US stocks. Stock Comparison: Compare Supernus Pharmaceuticals, Inc ...

Supernus Pharmaceuticals (SUPN) Q4 Earnings Beat Estimates. Supernus (SUPN) delivered earnings and revenue surprises of 8.77% and -6.36%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Find the latest Supernus Pharmaceuticals, Inc. (SUPN) stock quote, history, news and other vital information to help you with your stock trading and investing. Supernus Pharmaceuticals, Inc. Common Stock (SUPN) Stock ...

Apr 14, 2019 · Price Target: A price target is the projected price level of a financial security stated by an investment analyst or advisor . It represents a security's price that, if achieved, results in a

Nektar Therapeutics shares closed at $18.10 on Wednesday. Stifel Nicolaus lowered the price target on Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) from  There may be differences between the Equity Summary Score analyst count and the number of underlying analysts listed. Due to the timing in receiving ratings 

Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating ...

NASDAQ:SUPN | Analyst Ratings Mizuho Securities analyst Irina Rivkind Koffler reiterated a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report) today and set a price target of $63. The company’s shares closed yesterday at $34.38, close to its 52-week low of $30.05. Rivkind Are you still feeling insecure about Laredo Petroleum (LPI ... Mar 03, 2020 · Based on the latest results, analysts are suggesting that the target price for SUPN stock should be $18.70 per share in the course of the next 12 months. To achieve the target price as suggested by analysts, SUPN should have a spike by 0% in oppose to its present value in the market. Analyst Ratings for Supernus Pharmaceuticals (SUPN) SUPN Ratings News Supernus Pharmaceuticals (SUPN) Positive Phase 3 Excitement Dampened By Failure At 600mg - Mizuho Janney Montgomery Scott Resumes Supernus Pharmaceuticals (SUPN) at Buy Supernus Pharmaceuticals (SUPN) Gets a Buy Rating from ...

Supernus Pharmaceuticals, Inc. - SUPN - Stock Price Today ... View Supernus Pharmaceuticals, Inc. SUPN investment & stock information. Get the latest Supernus Pharmaceuticals, Inc. SUPN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SUPN Stock Quote - Supernus Pharmaceuticals, Inc. Common ... Stock quote for Supernus Pharmaceuticals, Inc. Common Stock Common Stock (SUPN) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.